Clinical trial

Broad Effectiveness: Study With Aripiprazole

NCT00036361

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-07-01

PhasePHASE3

Study timeline

Study start (unknown)2002-07-01Date precision: month

Registry last updated2013-11-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaverified · MONDO: schizophrenia

Schizoaffective Disorderverified · MONDO: schizoaffective disorder

Interventions

AripiprazoleDRUG · verified · RxNorm: aripiprazole

Sponsors & collaborators

Otsuka Pharmaceutical Development & Commercialization, Inc.lead sponsor

Otsuka America Pharmaceuticalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00036361 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.